Covid-19 rapid test developer acquired

0
969
Oxsed covid test
LinkedIn
Facebook
Twitter
Whatsapp
Telegram
Copy link

K&L Gates represented Hong Kong-based genetics and diagnostic health testing company Prenetics and its wholly-owned UK subsidiary DNAFit, in acquiring Oxsed, the developer of a rapid covid-19 testing method.

The Oxsed RaViD test provides test results within 30 minutes. Oxsed is led by two Chinese professors at Oxford University, chemical engineer Cui Zhanfeng and synthetic biologist Huang Wei. The Oxsed RaViD tests are already in use at London’s Heathrow airport and are planned for introduction at Hong Kong International Airport.

K&L Gates’ Hong Kong team in the deal was led by William Ho, with assistance from associates Eva Ying and Joey Liu. The firm’s London team was led by corporate partner Richard Dollimore with assistance from senior associate Sunny Kumar, associates Victoria Cormack, Emma Cooper and Keisha Phippen, and trainee solicitor Kira Green. UK partners Giles Bavister and Jennifer Marsh advised on UK tax aspects and regulatory aspects of the acquisition, respectively.

You must be a subscribersubscribersubscribersubscriber to read this content, please subscribesubscribesubscribesubscribe today.

For group subscribers, please click here to access.
Interested in group subscription? Please contact us.

你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章,欢迎成为我们的订阅会员成为我们的订阅会员

已有集团订阅,可点击此处继续浏览。
如对集团订阅感兴趣,请联络我们

LinkedIn
Facebook
Twitter
Whatsapp
Telegram
Copy link